NASDAQ:ALXO
ALX Oncology Holdings Inc. Stock News
$13.62
-0.170 (-1.23%)
At Close: May 21, 2024
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
11:13am, Tuesday, 09'th Nov 2021
ALX Oncology Holdings Inc (NASDAQ: ALXO) released additional data from a phase 1b trial of evorpacept in solid tumor malignancies. One cohort included gastric/gastroesophageal junction cancer patie
ALX Oncology to Present New Evorpacept Clinical Data in Myelodysplastic Syndromes at 63rd ASH Annual Meeting
09:00am, Thursday, 04'th Nov 2021
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block t
ALX Oncology Announces Upcoming Virtual Investor Conference Participation
09:00am, Tuesday, 02'nd Nov 2021
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block
ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio
07:00am, Thursday, 07'th Oct 2021
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company, and ScalmiBio, Inc. (“ScalmiB
-- Phase 1/2 study conducted at The University of Texas M.D. Anderson Cancer Center -- Phase 1/2 study conducted at The University of Texas M.D. Anderson Cancer Center
ALX Oncology Is The Next CD47 Biotech To Watch After Recent Acquisitions In This Space
11:43am, Wednesday, 08'th Sep 2021
ALX Oncology Is The Next CD47 Biotech To Watch After Recent Acquisitions In This Space
ALX Oncology Announces Upcoming Virtual Investor Conference Participation
07:00am, Tuesday, 07'th Sep 2021
BURLINGAME, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47
The 3 Best Biotech Stocks to Buy Right Now
06:55am, Friday, 27'th Aug 2021
Let your portfolio reflect your personality.
So What's Going On With ALX Oncology's Stock?
12:19pm, Monday, 23'rd Aug 2021
ALX Oncology Holdings Inc (NASDAQ: ALXO) shares are trading higher by 19.3% at $74.69, potentially in sympathy with Trillium Therapeutics which announced an acquisition by Pfizer Monday. ALX Oncology
ALX Oncology Shares Increase Over 25% Pre-Market: Why It Happened
08:19am, Monday, 23'rd Aug 2021
The shares of ALX Oncology Holdings Inc (NASDAQ: ALXO) increased by over 25% pre-market. This is why it happened.
ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
04:05pm, Thursday, 12'th Aug 2021
BURLINGAME, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47
This Biotech Stock Is Too Cheap to Ignore
09:40am, Thursday, 29'th Jul 2021
Wall Street's short attention span has created an attractive entry point in this once-loved biotech.
The second of two distinct randomized Phase 2 studies in collaboration with Merck has been initiated The second of two distinct randomized Phase 2 studies in collaboration with Merck has been initia
ALX Oncology (ALXO) Sees Hammer Chart Pattern: Time to Buy?
07:45am, Monday, 12'th Jul 2021
ALX Oncology (ALXO) has been struggling lately, but the selling pressure may be coming to an end soon.
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
10:16am, Tuesday, 06'th Jul 2021
Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ: ADXS) are among the bi
